STAT June 21, 2024
Elizabeth Cooney

ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem cells were able to produce enough of their own insulin to maintain healthy blood glucose levels 90 days later, Vertex Pharmaceuticals said Friday. All but one reduced or eliminated the need to inject insulin over those three months and three people followed for one year...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
FDA approves 1st RSV vaccine for adults under 60
Lawmakers seek answers on Pfizer, Lilly telehealth moves
Can Herbal Alternatives Ease the Economic Burden of Weight Loss Drugs?
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

Share This Article